Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.

Dutt A, Ramos AH, Hammerman PS, Mermel C, Cho J, Sharifnia T, Chande A, Tanaka KE, Stransky N, Greulich H, Gray NS, Meyerson M. · 2011

Read Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer. by Dutt A, Ramos AH, Hammerman PS, Mermel C, Cho J, Sharifnia T, Chande A, Tanaka KE, Stransky N, Greulich H, Gray NS, Meyerson M. (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3110189.txt.

Description

Amit Dutt and colleagues published a 2011 study in PLoS ONE hunting for drug targets in squamous lung cancer. This form of lung cancer causes many deaths each year, yet unlike other lung cancers it had no proven gene-targeted treatment. The team scanned tumour DNA for copied gene regions.

A stretch of one chromosome holding a growth receptor gene was copied extra times in about a fifth of squamous tumours and in a small share of other lung cancers. A cancer cell line with that extra copying died back when the receptor was blocked by gene silencing or by small drug molecules. The results mark this receptor as a promising target for a group of patients with few options.

Catalog record

CREATORDutt A, Ramos AH, Hammerman PS, Mermel C, Cho J, Sharifnia T, Chande A, Tanaka KE, Stransky N, Greulich H, Gray NS, Meyerson M.
YEAR2011
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3110189

Browse the full library · About the Tower of Babel